503A · CompoundedIllustration only. Actual medication will vary.Microdosing · Low-dose dual agonist
Microdose
Tirzepatide
A low-dose compounded tirzepatide protocol, one price at any microdose strength. Shipped in 30-, 60- or 90-day supplies.
Your Plan Options
Any microdose strength
Weekly injection · 30-day supply
$279 /mo
Any microdose strength
Weekly injection · 60-day supply
$529 /2 mo
Any microdose strength
Weekly injection · 90-day supply
$739 /3 mo
Best value
No charge until a provider prescribes. Prescription required.
Clinical information
What this is, in plain language.
Microdose tirzepatide uses lower doses of the dual GIP/GLP-1 receptor agonist tirzepatide than standard weight-management protocols. It is prepared by a licensed 503A compounding pharmacy and dispensed only when a licensed provider determines it is clinically appropriate.
Active ingredients
Tirzepatide (microdose strengths).
Mechanism
Dual GIP/GLP-1 receptor agonist at lower doses than standard protocols.
Administration
Once-weekly subcutaneous injection, as directed by your prescriber.
Who it is for
Adults seeking a gentler dual-pathway protocol, when clinically appropriate.
Common effects
Mild nausea, reduced appetite, injection-site reactions. Discuss full risks with your provider.
Important safety & compliance information
Compounded microdose tirzepatide is not FDA-approved. It is prepared by a licensed 503A compounding pharmacy and is descriptive only — it is not a branded drug. Product imagery shown here is illustration only; actual medication is dispensed in a pharmacy-labeled container and will vary in appearance. A prescription is required and is issued only when a licensed provider determines treatment is clinically appropriate. This page is not medical advice. Discuss benefits, risks and side effects with your provider.